Semen Analysis in India: WHO 2021 Criteria, Cost & Results

• Semen analysis checks sperm count, motility (movement) and morphology (shape) against the WHO 2021 lower reference limits — concentration 16 million/mL, total motility 42%, progressive motility 30%, normal forms 4%.
• A result below a WHO limit means 'lower fertility potential', not 'infertile'. Results vary a lot between samples, so one abnormal test should always be repeated 4–6 weeks later before any big decision.
• Abstain for 2–7 days (ideally 3–5), avoid lubricants, and get the sample to the lab within 1 hour at body temperature. Lab quality matters more than the lab's brand.
• Basic test costs roughly Rs 500–2,000 at diagnostic chains and Rs 1,000–3,500 at fertility-centre labs; AIIMS and other public hospitals charge Rs 100–500.
• The 'total motile count after wash' — not any single number — is what guides whether IUI, IVF or ICSI is recommended.
• Many mild abnormalities improve with 3 months of lifestyle change (weight, smoking, alcohol, heat, sleep), and most male-factor patterns are treatable.

A semen analysis is a lab examination of an ejaculated sample. It reports several things at once: sperm concentration (sperm per mL), total sperm count (concentration × volume), total motility (the share of sperm that move at all), progressive motility (the share moving forward effectively), morphology (the share with a normal shape), plus the volume, pH, appearance, viscosity and liquefaction time of the semen. It also flags round cells, clumping, or other abnormalities, and can include extra markers such as seminal fructose or a DNA fragmentation index.

The test matters because male factor contributes to about 40% of infertility seen in Indian clinics — as the sole cause in around 20% of couples and alongside a female factor in another 20%. Despite this, semen analysis is often left out of the first round of tests, done with poor protocols, or interpreted by someone who is not an andrologist. Any couple investigating unexplained or struggling-to-conceive issues should have a semen analysis as part of the baseline — starting treatment without it risks the wrong pathway. It also pairs naturally with the female-side basics like ovulation tracking and ovarian reserve (AMH) testing.

Abnormal patterns have specific names. Oligospermia is low concentration (under 16 million/mL); under 5 million/mL is severe. Asthenospermia is reduced movement. Teratospermia is abnormal shape. Oligoasthenoteratospermia (OAT) combines all three and is often the most significant pattern. Azoospermia means no sperm in the ejaculate, split into obstructive (production is fine but blocked) and non-obstructive (production itself is impaired).

Beyond the basics, advanced tests are used in specific situations: sperm DNA fragmentation index (DFI) when parameters are borderline or there is recurrent miscarriage; sperm chromatin structure assay (SCSA); reactive oxygen species (ROS); strict-criteria advanced morphology; FISH for sperm chromosomes; and Y-chromosome microdeletion testing in azoospermia. Each has its own indication and cost — they are not routine.

The WHO 2021 sixth-edition criteria are the current international reference, replacing the 2010 fifth edition. The limits are the 5th-percentile values from fertile men whose partners conceived within 12 months — so a number below a limit puts you in the lowest 5% of the fertile range and signals a closer look, not automatic infertility.

The key WHO 2021 lower reference limits are:

These numbers come with important caveats. A value below a limit means lower potential, not 'infertile'. A value above it is reassuring but does not guarantee conception. Crucially, results swing a lot between samples in the same man, so a single abnormal test should be confirmed with a repeat 4–6 weeks later before any major decision. And because these are statistical percentiles, a man at 15 million/mL is not meaningfully different from one at 17 million/mL despite sitting on opposite sides of the cut-off.

Other reported values: pH 7.2–8.0 (below 7.0 can suggest ejaculatory-duct obstruction or seminal-vesicle dysfunction), white blood cells under 1 million/mL (higher counts hint at a genital-tract infection needing treatment), plus notes on agglutination (clumping, sometimes from anti-sperm antibodies) and round cells (which need to be sorted into leukocytes vs immature germ cells).

Versus 2010, the 2021 edition lowered progressive motility from 32% to 30% and kept normal morphology at 4% strict criteria. Its bigger message was about standardised laboratory technique and quality control — lab-to-lab variability is a major source of error, which is exactly why choosing a lab that genuinely follows WHO 2021 protocols matters more than its brand name.

Preparation changes the result, so get it right. Abstain for 2–7 days, ideally 3–5. Less than 2 days lowers volume and can fake a low concentration; more than 7 days raises the share of dead sperm and can fake low motility. Skip alcohol, smoking and recreational drugs for at least a week beforehand. Because a high fever knocks out sperm production for 2–3 months, a fever in the past 8–10 weeks means the result may not reflect your baseline — note it to the lab. Avoid hot tubs, saunas and laptops on the lap for 2–4 weeks before testing.

Collect the sample by masturbation into a sterile, wide-mouth container supplied by the lab. Lab collection in a private room is ideal because analysis can start within minutes. Home collection is acceptable only if the lab is within an hour's transport and the sample is kept at body temperature (held against the body) on the way. If masturbation is not feasible for personal or religious reasons, special non-spermicidal collection condoms are available from labs on request — ordinary condoms contain spermicide and ruin the sample. Never use lubricants or saliva; they impair motility.

Choose a lab that follows WHO 2021 protocols. In practice the most reliable analyses often come from fertility-centre embryology labs (Apollo Fertility, Nova IVF, Indira IVF, Cloudnine, Bloom IVF, Ferty9, Oasis), because they process semen for IVF and ICSI every day. Diagnostic chains (Dr Lal PathLabs, Metropolis, Thyrocare, SRL) are variable but usually fine for screening, and dedicated andrology labs in big cities are best for complex cases. A poorly done semen analysis is worse than none, because it misleads treatment — so pay for quality when the result will drive decisions.

Finally, repeat testing is part of the process, not a sign something went wrong. Single results vary with illness, stress, technique and lab handling, so WHO recommends 2–3 samples spaced 4–6 weeks apart to set a true baseline. No major decision — IVF with ICSI, donor sperm, a surgical sperm retrieval — should rest on one abnormal test. If a specialist proposes major treatment after a single result, it is entirely reasonable to ask for a repeat first.

A basic semen analysis (concentration, motility, morphology, volume) runs about Rs 500–2,000 at major diagnostic chains: Dr Lal PathLabs roughly Rs 800–1,500, Metropolis Rs 700–1,500, Thyrocare Rs 600–1,200, SRL Rs 800–1,500. Quality varies — some chains use trained andrologists and rigorous protocols, others do basic counts only. At fertility-centre embryology labs (Apollo Fertility, Nova IVF, Indira IVF, Cloudnine, Bloom IVF, Ferty9, Oasis, Manipal Fertility, Bourn Hall), the same test costs Rs 1,000–3,500, usually with stricter WHO 2021 compliance and andrologist interpretation.

Advanced tests cost more, and you only need them if indicated:

Public-sector labs at AIIMS Delhi, JIPMER, KEM Mumbai, PGIMER Chandigarh and similar centres charge only Rs 100–500. Quality is generally good (AIIMS in particular has trained andrologists), the trade-off being waiting times and logistics. For couples on a tight budget, this is a sound option if the timeline works.

Home collection from diagnostic chains usually adds Rs 100–300, but for semen specifically it is awkward — the sample must reach the lab within an hour at body temperature, so many chains do not offer it. Lab-based collection in a private room remains the most reliable route, and some fertility centres have dedicated, comfortable collection rooms that make it easier.

A fully normal result (all parameters within WHO 2021 ranges) means the male contribution sits in the fertile range — though it cannot guarantee fertility, because subtle issues like DNA fragmentation are not picked up by a basic test. If the couple still is not conceiving with a normal analysis, the next steps shift to the female workup and an unexplained infertility evaluation, with a confirmatory repeat in 4–6 weeks.

Mild abnormalities — one or two parameters just below the limit, like 14 million/mL concentration or 28% progressive motility — often carry little real-world weight. The sensible plan is a repeat to confirm, a parallel female workup, and a trial of natural or timed conception before considering assisted reproduction. Many couples in this group conceive on their own.

Moderate-to-severe OAT — concentration under 10 million/mL with motility and morphology also impaired — usually points toward assisted reproduction, and the choice hinges on the post-wash total motile count: above 10 million suggests IUI may work (roughly 8–15% per cycle); 5–10 million leans toward IVF; under 5 million typically needs IVF with ICSI for adequate fertilisation. Severe oligospermia (under 5 million/mL) is usually ICSI first-line. If you are weighing options, our IUI vs IVF decision guide and the IVF cost and success-rate breakdown walk through the trade-offs.

Azoospermia (no sperm in the ejaculate) needs further testing to separate obstructive from non-obstructive causes. Obstructive azoospermia (production normal but blocked — absent vas deferens, prior vasectomy, infection-related blockage) shows a normal hormone profile and is confirmed when a retrieval procedure (TESA, PESA) finds sperm for ICSI. Non-obstructive azoospermia (impaired production — Y-microdeletion, Klinefelter syndrome, hypogonadotropic hypogonadism, post-chemotherapy failure) shows a raised FSH and may or may not yield sperm via micro-TESE. Where retrieval is not possible or not wanted, donor sperm IUI is a route many couples take.

Mild (post-wash total motile count above 10 million). Repeat the analysis in 4–6 weeks; complete the female workup in parallel (HSG, AMH, antral follicle count); make lifestyle changes that can lift parameters over about 3 months; and try 3–6 months of natural conception before assisted reproduction. Many couples here conceive without intervention.

Moderate (oligospermia 5–15 million/mL, motility 20–30%, post-wash count 5–15 million). Repeat and complete the female workup; actively look for treatable causes — a varicocele on exam and Doppler, hormonal imbalance on FSH/LH/testosterone/prolactin, infection on urine and prostatic-fluid testing. Treat what is found (varicocele repair, hormone replacement, antibiotics), then typically move to IUI with ovulation induction (3–4 cycles, around Rs 15,000–30,000 each), stepping up to IVF/ICSI if IUI fails.

Severe (oligospermia under 5 million/mL, severe motility issues, post-wash count under 5 million). Confirm with a repeat; add a genetic workup (karyotype, Y-microdeletion); run a hormone panel; and screen for Klinefelter syndrome. Because IUI success here is essentially zero, IVF with ICSI is usually first-line, with sperm retrieval in selected cases and donor sperm as an alternative.

Azoospermia. The workup includes a hormone panel (FSH, LH, testosterone, sometimes prolactin and TSH) to separate obstructive from non-obstructive, karyotype and Y-microdeletion testing, scrotal ultrasound, and transrectal ultrasound if ejaculatory-duct obstruction is suspected. Surgical retrieval (TESA, PESA, micro-TESE) provides sperm for ICSI where possible, with donor sperm as a fallback. This pathway needs an experienced fertility specialist and andrologist working together.

Lifestyle changes have genuine, if gradual, effects over about 3 months. Sperm takes roughly two-and-a-half months to mature, so the benefits of today's changes show up in a sample taken later:

Some environmental factors are worth actively avoiding. Scrotal heat is a big one — the testes need to sit 2–3°C below body temperature, so hot tubs, saunas, very tight underwear, laptops on the lap and hot occupational settings all hurt. So do pesticides, heavy metals (lead, mercury, cadmium), industrial solvents and BPA plastics, occupational radiation, and certain medicines — notably testosterone supplements (which paradoxically lower count), anabolic steroids, sulfasalazine, and some antidepressants and calcium-channel blockers.

Medical treatment targets the specific cause. That can mean microsurgical varicocele repair when a palpable varicocele goes with significant abnormalities; FSH/LH replacement in hypogonadotropic hypogonadism; antibiotics for a confirmed infection; treating systemic disease like thyroid dysfunction or diabetes; swapping out a sperm-toxic medication; or surgery for ejaculatory-duct obstruction or retrograde ejaculation. If a raised prolactin is found, treating it can restore the hormonal axis.

Supplements have a supporting role, not a starring one. Combinations such as zinc, folic acid, vitamin C, vitamin E, selenium, coenzyme Q10, L-carnitine and omega-3s are sold widely in India (Fertis-M, Q-Sper and similar) at roughly Rs 800–2,500 a month. Evidence is modest — typically 10–30% improvement over 3–6 months — so they complement lifestyle and medical treatment rather than replacing them. We separate the evidence from the marketing in male fertility — myths vs reality.

Sperm DNA fragmentation index (DFI) measures the share of sperm with damaged DNA — damage that can exist even when the basic numbers look normal. A high DFI (above about 25–30%, depending on method) is linked to lower fertilisation, poorer embryos, higher miscarriage risk and lower live-birth rates in IUI and IVF. It is worth testing when there is unexplained infertility with a normal basic analysis, recurrent IVF failure despite good-looking embryos, recurrent pregnancy loss, advanced paternal age (over 40–45), toxic occupational exposure or a varicocele. Cost is Rs 5,000–12,000.

Genetic testing is indicated for severe oligospermia (under 5 million/mL), non-obstructive azoospermia, or syndromic features. A karyotype (Rs 3,000–6,000) screens for Klinefelter syndrome (XXY) and translocations; Y-chromosome microdeletion testing (Rs 5,000–15,000) looks at the AZF regions tied to severe spermatogenic failure; and CFTR (cystic fibrosis) carrier testing (Rs 5,000–10,000) is relevant because those mutations cause congenital absence of the vas deferens with obstructive azoospermia.

Hormone testing maps the hypothalamic-pituitary-testicular axis. The standard panel reads FSH (high suggests testicular failure; low points upstream to the pituitary/hypothalamus), LH, testosterone, prolactin (high levels suppress testosterone and impair sperm), and TSH, with estradiol in selected cases. Cost is Rs 1,500–4,000.

Other tests are used selectively: anti-sperm antibody testing (when clumping is seen), seminal-fluid biochemistry (fructose, neutral alpha-glucosidase, zinc and citrate to localise the problem), post-ejaculate urine analysis for suspected retrograde ejaculation, scrotal Doppler and transrectal ultrasound, and — rarely now — a diagnostic testicular biopsy. Which ones you need depends entirely on the clinical picture and the basic analysis.

For an initial interpretation and basic evaluation, an ISAR-member fertility specialist (reproductive endocrinologist) at a recognised IVF centre is usually the right first stop. They understand both partners' factors and can coordinate the couple's workup. Most major chains (Apollo Fertility, Nova IVF, Indira IVF, Cloudnine, Bloom IVF, Ferty9, Oasis) handle male factor as part of couple evaluation, with consultation fees around Rs 800–2,500.

For complex male factor — severe oligospermia, azoospermia, suspected genetic causes, or a varicocele needing surgery — an andrologist (a urologist specialising in male reproductive health) is the right specialist. They perform surgical sperm retrieval (TESA, PESA, micro-TESE), varicocele repair and ejaculatory-duct surgery. Strong andrology services sit in the urology departments at Apollo Hospitals, AIIMS Delhi, Tata Memorial Mumbai, PGIMER Chandigarh and JIPMER Puducherry, plus specialised private clinics in the metros.

When a genetic cause is found, a clinical geneticist or genetic counsellor can explain inheritance, implications and reproductive options — especially important for Y-microdeletion, Klinefelter syndrome, translocations and CFTR-related absent vas deferens. AIIMS Delhi, Tata Memorial, Apollo and Manipal have established genetics services.

Finally, do not overlook emotional support. Indian cultural framing around male fertility can be brutal, and many men carry real distress with little room to express it. Clinic-based counsellors, ISAR Counselling SIG members and men's support groups genuinely help — and so can going through the emotional side of conception as a couple together rather than alone.

A semen analysis is part of a planned fertility check-up rather than an emergency, but book one — and a fertility consultation — if any of the following apply:

Some findings need prompt, not routine, attention. Azoospermia, severe oligospermia, a hormone abnormality, or signs of infection (pain, swelling, fever, discharge) should be reviewed by a fertility specialist or andrologist without long delays. And if a clinician recommends major treatment such as IVF with ICSI, donor sperm or a surgical procedure on the basis of a single abnormal result, ask for a confirmatory repeat first — that is good practice, not obstruction.

Before the test, ask the lab or clinic: what abstinence period do you recommend (it should be 2–7 days, ideally 3–5); should I collect at the lab or at home (lab is preferred); do you provide a sterile, wide-mouth container; do you follow WHO 2021 protocols with a trained andrologist; what does it cost and what is included; when will results be ready; can a fertility specialist here interpret them or do I need a separate consult; and what happens if I cannot produce a sample on the day.

After results, ask the interpreting specialist: are all parameters within WHO 2021 ranges, and what do any abnormalities mean; do you recommend a repeat, and when; what is my post-wash total motile count (the number that actually drives treatment); what is the next step (hormones, genetics, scrotal ultrasound, varicocele check, DFI); and how does my result combine with my partner's to shape the plan.

If treatment is recommended, ask: is this based on one test or several confirmed ones; have you ruled out and treated reversible causes (varicocele, hormones, infection, medication) first; what are the realistic per-cycle and cumulative success rates for my specific numbers; what are the alternatives and why this one; and what is the full cost breakdown.

Watch for red flags: a lab with no clear WHO 2021 compliance; major recommendations after one unconfirmed result; pushing IVF/ICSI when IUI might have worked given the total motile count; skipping reversible causes; quoting unrealistic success rates; or pressure to start immediately. A good evaluation is thorough, evidence-based and tries the simplest effective step first.

• WHO laboratory manual for the examination and processing of human semen, 6th edition (2021)
• WHO — Infertility fact sheet
• NICE — Fertility problems: assessment and treatment (CG156)
• NHS — Infertility: diagnosis and treatment
• American Urological Association / ASRM — Diagnosis and Evaluation of Infertility in Men